UiPath (NYSE:PATH – Free Report) had its price target reduced by BMO Capital Markets from $16.00 to $11.50 in a report ...

Bank of Montreal’s veteran oil and gas analyst is making the case for a four-way mega merger in Western Canada’s Montney Formation, arguing such a deal would boost scale and broaden investor appeal.

BMO Capital Markets assumed coverage on shares of Avidity Biosciences (NASDAQ:RNA – Free Report) in a research note issued to investors on Wednesday, MarketBeat Ratings reports. The brokerage ...

BMO Capital Markets initiated coverage on Dyne Therapeutics (DYN, Financials) with an Outperform rating and a $50 price target, suggesting a strong upside from the company's current share price of ...

BMO Capital Markets upgraded Block (NYSE:XYZ) to Outperform from Market Perform as analyst Rufus Hone sees the potential for investor sentiment to improve through 2025 as Cash App/Square gross ...

Investing.com -- BMO Capital Markets upgraded Century Aluminum Company (NASDAQ:CENX) to "Outperform" from "Market Perform" given its favourable valuation following a recent sell-off and the ...

BMO Capital upgraded Goeasy (EHMEF) to Outperform from Market Perform with a price target of C$200, down from C$207. Goeasy trades at trough multiples on tariff-scenario earnings, effectively ...

BMO Capital raised the firm’s price target on Okta (OKTA) to $130 from $105 and keeps a Market Perform rating on the shares. The firm had been ...